Trial Profile
Quillivant XR in Children With Attention Deficit/Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD): A Pilot Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2017
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder; Autistic disorder
- Focus Therapeutic Use
- 25 Apr 2017 Status changed from recruiting to completed.
- 09 Oct 2014 New trial record